TL;DR
This study investigates the role of the 17-beta hydroxysteroid dehydrogenase 2 (hsd17b2) gene in sex reversal in the ricefield eel, a protogynous hermaphroditic fish. Researchers cloned the gene, analyzed its expression patterns in different tissues and developmental stages, and examined how hormone treatments affect its activity, suggesting hsd17b2 is a key regulator in the fish's sex differentiation process.
What Problem Does This Paper Address?
While the 17-beta hydroxysteroid dehydrogenase 2 (hsd17b2) enzyme is known in mammals to regulate estrogen and androgen activity, its specific function in animal sex differentiation, particularly in fish, remains largely unclear. The ricefield eel (Monopterus albus) is an ideal model for studying sex differentiation due to its hermaphroditic nature and relatively small genome. This paper aims to fill the knowledge gap by characterizing the hsd17b2 gene in this species and exploring its involvement in the complex process of sex reversal.
Methods
The researchers employed a multi-pronged approach:
- Gene Cloning and Sequencing: They cloned the cDNA fragment of the hsd17b2 gene from the ricefield eel and determined its sequence.
- Bioinformatics Analysis: They analyzed the protein sequence for conserved domains (like the Rossmann-fold domain characteristic of SDR superfamily enzymes), predicted its structure (ribbon diagram), and assessed its hydrophilicity and potential for being a secretory protein.
- Gene Expression Profiling (RT-qPCR): They used quantitative reverse transcription polymerase chain reaction (RT-qPCR) to measure the mRNA expression levels of hsd17b2 in various adult tissues (intestine, brain, heart, liver, spleen, kidney, testis, and ovary) and in gonads at different developmental stages of sex reversal. They also used zar1, an oocyte-specific marker, as a control.
- Cellular Localization (Chemical in Situ Hybridization - CISH): They used CISH to visualize where hsd17b2 mRNA was located within the gonadal tissues at different developmental stages.
- Hormonal Treatment: They treated ovarian tissues in vitro with various hormones and hormone inhibitors (17ß-estradiol (E2), E2 inhibitor (E2I), melatonin (MT), and androgen inhibitor (AI)) and then used RT-qPCR to assess the impact on hsd17b2 mRNA expression.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Conserved but Divergent: The ricefield eel's hsd17b2 gene shares conserved functional motifs with its mammalian counterparts, particularly in the Rossmann-fold domain crucial for cofactor binding. However, significant sequence divergence, especially in the N-terminal region, suggests potential functional differences and adaptation to aquatic environments.
- Ovary-Centric Expression: The gene's mRNA is predominantly expressed in the ovaries, especially during early developmental stages, and its expression pattern follows an "M-shape" curve during sex reversal, peaking in early ovotestis and then declining towards testis. This strongly implicates it in oogenesis and the transition to maleness.
- Hormonal Sensitivity: hsd17b2 expression is significantly influenced by sex hormones. While low concentrations of E2I and high concentrations of MT and AI suppress its expression, high concentrations of E2I appear to stimulate it. This highlights its role in maintaining sex hormone balance.
- Potential Role in Steroid Metabolism: The study suggests hsd17b2 may be involved in converting testosterone to androstenedione, a key step in steroid metabolism that could initiate sex reversal.
Key Results
- The cloned hsd17b2 cDNA fragment is 1230 bp, encoding a 368-amino acid protein with conserved SDR superfamily features.
- hsd17b2 mRNA is highly expressed in ovaries, weakly in liver and intestine, and minimally in other tissues.
- Expression peaks in young fish ovaries and early ovotestis, then declines in later ovotestis and testis.
- CISH reveals hsd17b2 mRNA is localized in oogonia, primary oocytes, and granulosa cells, but absent in mature oocytes and male germ cells.
- Low concentrations of E2 and E2I significantly reduced hsd17b2 mRNA expression, while high concentrations of E2I increased it.
- MT and AI treatments significantly suppressed hsd17b2 mRNA expression.
Limitations and Future Work
- Functional Validation: While the study provides strong correlative evidence, direct functional validation of hsd17b2's enzymatic activity and its precise role in steroid conversion in vivo would strengthen the conclusions.
- In Vivo Hormone Studies: The hormonal treatments were performed in vitro on ovarian tissues. Future work could involve in vivo studies to confirm these findings in the context of the whole organism and its complex endocrine system.
- Mechanism of E2I Stimulation: The observation that high concentrations of E2I stimulate hsd17b2 expression warrants further investigation to understand the underlying molecular mechanisms.
- Broader Species Comparison: While the study provides phylogenetic context, further comparative genomics and functional studies across a wider range of hermaphroditic fish could reveal more about the evolutionary trajectory and functional diversification of hsd17b2.
Summary updated